Jeff Yass Susquehanna International Group
Jeff Yass is a co-founder of Susquehanna International Group (SIG), a major global trading and market-making firm. SIG is known for options expertise, quantitative trading, and a training culture grounded in probabilistic decision-making. Yass’s firm is influential across derivatives markets even though it is less of a traditional long-only stock-picking franchise.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$879M |
| 2 |
Bank of America
BAC
|
+$352M |
| 3 |
Intel
INTC
|
+$243M |
| 4 |
VanEck Gold Miners ETF
GDX
|
+$232M |
| 5 |
AB InBev
BUD
|
+$188M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$1.82B |
| 2 |
Amazon
AMZN
|
+$884M |
| 3 |
Air Products & Chemicals
APD
|
+$219M |
| 4 |
Mondelez International
MDLZ
|
+$198M |
| 5 |
WFT
Weatherford International plc
WFT
|
+$181M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 1.22% |
| 2 | Technology | 1.15% |
| 3 | Consumer Discretionary | 1.1% |
| 4 | Financials | 1.05% |
| 5 | Communication Services | 0.98% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
CELG
76
CALL
DELISTED
Celgene Corp
CELG
| $405M | 0.21% |
3,256,600
+220,800
| +7% | +$26.4M |
|
77
PUT
Johnson & Johnson
JNJ
$651B
| $397M | 0.2% |
3,190,700
-570,400
| -15% | -$68.1M |
|
78
PUT
JPMorgan Chase
JPM
$935B
| $393M | 0.2% |
4,473,200
-767,300
| -15% | -$67.7M |
|
|
79
Amazon
AMZN
$2.79T
| $392M | 0.2% |
8,838,300
-21,209,820
| -71% | -$884M |
|
80
PUT
Bristol-Myers Squibb
BMY
$137B
| $388M | 0.2% |
7,143,700
+1,708,700
| +31% | +$93.7M |
|
81
PUT
Berkshire Hathaway Class B
BRK.B
$1.06T
| $383M | 0.19% |
2,295,800
+874,000
| +61% | +$146M |
|
82
PUT
ExxonMobil
XOM
$679B
| $379M | 0.19% |
4,626,600
-162,600
| -3% | -$13.6M |
|
83
CALL
AbbVie
ABBV
$468B
| $379M | 0.19% |
5,818,100
+1,778,000
| +44% | +$112M |
|
84
PUT
State Street SPDR S&P Oil & Gas Exploration & Production ETF
XOP
$3.93B
| $372M | 0.19% |
2,486,950
+777,300
| +45% | +$121M |
|
85
PUT
Procter & Gamble
PG
$336B
| $366M | 0.19% |
4,078,300
-68,300
| -2% | -$6.06M |
|
|
86
PUT
Intel
INTC
$476B
| $366M | 0.19% |
10,145,000
+3,930,300
| +63% | +$142M |
|
87
CALL
Merck
MRK
$376B
| $366M | 0.19% |
6,033,860
+1,575,982
| +35% | +$95.6M |
|
88
PUT
AT&T
T
$173B
| $365M | 0.18% |
11,616,114
-959,238
| -8% | -$30.2M |
|
89
CALL
GE Aerospace
GE
$361B
| $360M | 0.18% |
2,518,489
-414,486
| -14% | -$60M |
|
90
PUT
DuPont de Nemours
DD
$18.7B
| $355M | 0.18% |
2,209,123
+1,120,120
| +103% | +$174M |
|
|
91
CALL
ExxonMobil
XOM
$679B
| $352M | 0.18% |
4,289,200
-3,352,500
| -44% | -$280M |
|
92
PUT
Amgen
AMGN
$238B
| $351M | 0.18% |
2,140,000
+417,400
| +24% | +$69.4M |
|
93
PUT
SPDR Gold Trust
GLD
$152B
| $344M | 0.17% |
2,895,600
-1,726,300
| -37% | -$201M |
|
94
PUT
State Street Financial Select Sector SPDR ETF
XLF
$57.8B
| $342M | 0.17% |
14,411,000
+4,230,100
| +42% | +$101M |
|
|
95
CALL
Bristol-Myers Squibb
BMY
$137B
| $338M | 0.17% |
6,223,900
+2,875,300
| +86% | +$158M |
|
96
PUT
Verizon
VZ
$205B
| $336M | 0.17% |
6,877,600
+1,864,000
| +37% | +$93.5M |
|
|
97
PUT
VanEck Gold Miners ETF
GDX
$31.8B
| $335M | 0.17% |
14,678,900
+556,600
| +4% | +$12.9M |
|
98
CALL
Boeing
BA
$169B
| $333M | 0.17% |
1,882,300
-308,300
| -14% | -$52.5M |
|
99
CALL
Chevron
CVX
$403B
| $331M | 0.17% |
3,078,500
-101,800
| -3% | -$11.4M |
|
100
PUT
Walt Disney
DIS
$186B
| $330M | 0.17% |
2,907,300
-597,900
| -17% | -$65.8M |
|
Similar funds
Jeff Yass's Q1 2017 Portfolio in Review
As of Q1 2017, Jeff Yass held 10,995 positions worth $198B, up 0.36% from $197B the previous quarter. Its ten largest holdings account for 22% of the portfolio.
Jeff Yass withdrew a net $14.4B in Q1 2017, closing 2,170 positions and reducing 3,726 holdings. Its most notable exit was Air Products & Chemicals, an estimated $219M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 1.2% of assets, down from 1.2% a quarter earlier, followed by Technology and Consumer Discretionary.
Against the trend, Jeff Yass opened a new position in iShares MSCI EAFE ETF worth $131M.
- Jeff Yass's largest Q1 2017 buy was iShares MSCI EAFE ETF: 2,100,985 shares worth $131M.
- Jeff Yass added most to State Street SPDR S&P 500 ETF Trust in Q1 2017, an estimated $879M increase.
- Jeff Yass's biggest Q1 2017 reduction was Apple, cutting an estimated $1.82B.
- Jeff Yass fully exited Air Products & Chemicals in Q1 2017, selling an estimated $219M.
- Jeff Yass's ten largest holdings make up 22% of its $198B portfolio in Q1 2017.
- Jeff Yass opened 1,488 new positions and closed 2,170 in Q1 2017.
- Jeff Yass's portfolio value rose 0.36% quarter-over-quarter to $198B.
Based on Susquehanna International Group's 13F filing for Q1 2017, filed 15 May 2017.